Evidence map›Paper›PMID 32273287›Full record

ArticleGenes & development2020

REDD1 loss reprograms lipid metabolism to drive progression of

Shuxi Qiao, Siang-Boon Koh, Varunika Vivekanandan, Devika Salunke, Krushna Chandra Patra, Elma Zaganjor, Kenneth Ross, Yusuke Mizukami, Sarah Jeanfavre, Athena Chen and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Development of fatty acid metabolism score based on gene signature for predicting prognosis and immunotherapy response in colon cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Benzo[ACS medicinal chemistry letters · 2022
    Article
  15. The mMolecular cancer · 2022
    Article
  16. Nutritional Sensor REDD1 in Cancer and Inflammation: Friend or Foe?International journal of molecular sciences · 2022
    Review
  17. CD36: an emerging therapeutic target for cancer and its molecular mechanisms.Journal of cancer research and clinical oncology · 2022
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Shuxi Qiao *Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Siang-Boon Koh *Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Varunika VivekanandanMassachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Devika SalunkeMassachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Krushna Chandra PatraMassachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Elma ZaganjorLudwig Cancer Center at Harvard, Harvard University, Boston, Massachusetts 02115, USA.
Kenneth RossMassachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Yusuke MizukamiMassachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Sarah JeanfavreBroad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
Athena ChenHarvard Medical School, Boston, Massachusetts 02115, USA.
Mari Mino-KenudsonMassachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Sridhar RamaswamyMassachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Clary ClishBroad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts 02142, USA.
Marcia HaigisLudwig Cancer Center at Harvard, Harvard University, Boston, Massachusetts 02115, USA.
Nabeel BardeesyMassachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.
Leif W EllisenMassachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA.ORCID 0000-0003-0444-7910
Harvard University · USBroad Institute · USMassachusetts General Hospital · US

Funding

ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Elizabeth Austen Lawson, Takara Leah Stanley · 1994 to 2026
$31.6M
Function and mechanism of REDD1 signaling to TSC1/2 and mTORC1R01CA122589 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI ELLISEN, LEIF W · 2007 to 2017
$3.2M
NCI NIH HHS R01 CA122589NIDDK NIH HHS P30 DK040561
6 · The paper itself

Abstract

Human cancers with activating

Indexed as

AnimalsCell Line, TumorDisease ProgressionFatty AcidsHEK293 CellsHumansLipid MetabolismMiceMice, SCIDMutationOxidation-Reductionras ProteinsTranscription FactorsDdit4 protein, mouseFatty Acidsras ProteinsTranscription Factorsenergy stressfatty acid oxidationglycolysislipid metabolismlysophospholipidsmetastasisoxidative stressRASREDD1

Identifiers

PMID32273287
PMCPMC7263146
OpenAlexW3015285607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.